Integrated Germline and Somatic Molecular Profiling to Detect Cancer Predisposition Has a High Clinical Impact in Poor-Prognosis Pediatric Cancer.

Integrated tumor/germline genomic profiling: +7.9% yield vs standard care

A prospective national Australian study performed real-time integrated tumor/germline genomic profiling in 496 consecutive children with poor-prognosis cancers. Germline pathogenic variants (GPVs) were identified in 15.5% of patients, with an incremental yield of 7.9% above standard care. Although 43.7% of GPVs were outside the recognized phenotypic spectrum of predisposition, 63.2% of these atypical cases were clinically actionable. Integrated germline-tumor analysis increased detection by 8.5%, and 47.8% of inherited GPVs had direct risk management implications for the carrier parent.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

This study strongly supports integrated tumor-germline WGS in poor-prognosis pediatric oncology: more than one in seven children carries a predisposition variant, and the large majority are clinically actionable even outside the typical spectrum. The cascade impact on parents (47.8% requiring risk management) alone justifies the systematic approach. The challenge remains integration into routine care pathways.

Clinical impact : 3/3 · Evidence quality : 2/3 · Novelty : 2/2 · Sample size : 1/1 · Journal quality : 1/1 → Total : 9/10